ICHTHOPASTE Bandage
Aids the healing of venous leg ulcers and associated skin conditions
Containing 6.32% zinc oxide and 2% ichthammol, ICHTHOPASTE Bandage is suitable for use in adults and children. It provides a versatile topical treatment to support the healing of venous leg ulcers and for managing a myriad of dermatological conditions. Ichthammol is oil based, which helps to treat chronic wet and itchy eczema, chronic venous eczema, dermatitis and chronic lichenified conditions of the skin such as hyperkeratosis(1).
- 6.32% Zinc Oxide and 2% ichthammol formulation
- Single-use, non-elastic cotton bandage
- Suitable for use as the primary contact layer
- Anti-fungal
- Helps manage skin hydration
- Highly conformable to all leg shapes
ICHTHOPASTE provides a protective oil layer on the skin to help prevent excess trans-epidermal water loss, maintain skin hydration, and reduce the hardening and thickening of the skin(2).
When combined with zinc oxide, ICHTHOPASTE supports a moist wound-healing environment, while its anti-pruritic and anti-fungal properties help break the itch-scratch cycle often experienced in the management of psoriasis and eczematous dermatitis, and other dermatoses(3).
ICHTHOPASTE bandage contains no elastic fibres and does not stretch, so it must be applied as directed(2). It can be used as a primary contact layer over the wound or skin condition and should be covered with a retention bandage or, if appropriate, a compression therapy system**.
Ordering Information: (Only available in New Zealand)
| Code | Description | Size |
| 4959 |
Bandage (UoM: Carton of 12 eaches) |
7.5 cm x 6 cm |
Soothing and comfortable to wear
Zinc Oxide paste bandages and stockings can be worn over wounds and damaged skin. They help to relieve the irritation, breaking the itch-scratch cycle*. A cost-effective treatment which is easy to apply and remove. Improved healing rates may be achieved. Suitable for use on all ages.
**Where venous insufficiency exists, ICHTHOPASTE can be used under graduated compression bandages after first assessing the patient to exclude arterial disease.
References:
1. Boyd AS (2010) Ichthammol revisited. Int J Dermatol 49: 757–60. 2. Evolan Pharma AB (2020) Data on file. Danderyd, Sweden. 3. Gayko G. Cholcha W, Keitzmann M (2000) Anti-inflammatory, antibacterial and anti-mycotic effects of dark sulfonated shale oil (Ichthammol). Sonderdruck aus Berl. Munch. Tierarztl. Wochenschr. 113, Heft 10.
Whilst we make every effort to ensure that the information contained on this site is accurate, it is not a substitute for medical advice or treatment, and Evolan Pharma recommends consultation with your doctor or health care professional. Evolan Pharma cannot accept liability for any loss or damage resulting from any inaccuracy in this information or third-party information such as information on websites to which we link. The information provided is intended to support patients and clinicians, not to provide personal medical advice.